| New Biomarkers in Pancreatic Cancer Using EXPEL Concept (NCT03791073) | University Hospital, Montpellier | 2018-01-01 |
| Embryonic Ploidy Status in the Oncofertility Population (NCT03350230) | Reproductive Medicine Associates of New Jersey | 2017-12-01 |
| Intelligent Electric Bicycle for Health (VELIS) to Optimize the Return to Physical Activity for Oncology Patients (NCT03340857) | Fondation Audavie | 2017-10-09 |
| Risk Scoring Model for Endometrial Cancer (NCT03298100) | Ain Shams University | 2017-09-26 |
| RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy (NCT03118986) | The Hospital for Sick Children | 2017-08-10 |
| Responsible Side Effects Management in Oncology (NCT04623437) | University Hospital Sestre Milosrdnice | 2017-07-01 |
| Irreversible Electroporation for Treatment of Solid Abdominal Tumors (NCT03169439) | Assiut University | 2017-07-01 |
| Modeling of the Response to Hypofractionated Stereotactic Pulmonary Irradiation (NCT03175861) | University Hospital, Brest | 2017-06-14 |
| POA Prospective Repository (NCT03324841) | Caris Science, Inc. | 2017-06-07 |
| A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) (NCT03121768) | Mansoura University | 2017-05-15 |
| Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders (NCT03147599) | Mansoura University | 2017-05-15 |
| Geriatric Oncology Follow-up in the Alpine Valley (NCT03349229) | University Hospital, Grenoble | 2017-04-01 |
| Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy (NCT03147586) | Mansoura University | 2017-03-01 |
| Characteristics of the Intestinal Microbiota in Patients With Cancer (NCT03196609) | Centre Georges Francois Leclerc | 2017-02-06 |
| Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors (NCT02931864) | National University of Singapore | 2016-12-06 |
| POA Retrospective Repository (NCT03326479) | Caris Science, Inc. | 2016-11-30 |
| Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies (NCT02906670) | Symphogen A/S | 2016-11-01 |
| A Psycho-educational Intervention for Symptom Cluster Management (NCT03332199) | Hanoi Medical University | 2016-09-01 |
| The BRAvAdO Registry (NCT04222608) | University of Sao Paulo General Hospital | 2016-09-01 |
| Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status (NCT02835937) | Mayo Clinic | 2016-09-01 |
| Support of the Sexual Health in Oncology (NCT03166774) | Fondation Hôpital Saint-Joseph | 2016-06-06 |
| Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria (NCT02733601) | AstraZeneca | 2016-05-29 |
| Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients (NCT03951090) | UNC Lineberger Comprehensive Cancer Center | 2016-04-25 |
| Comprehensive Segmental Revision System (NCT03270982) | Zimmer Biomet | 2016-04-01 |
| Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies (NCT02648724) | Symphogen A/S | 2016-03-01 |
| Database for Data Collection in the Context of an Enhanced Recovery After Surgery Program in Oncology Surgery (NCT03950011) | Institut Paoli-Calmettes | 2016-01-01 |
| Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function (NCT02521376) | Gilead Sciences | 2015-11-16 |
| Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients (NCT03067012) | Seoul National University Bundang Hospital | 2015-09-01 |
| A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection (NCT02629458) | The Leeds Teaching Hospitals NHS Trust | 2015-07-01 |
| An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers. (NCT02479061) | Centre Leon Berard | 2015-06-01 |
| Safety Study of AMG 228 to Treat Solid Tumors (NCT02437916) | Amgen | 2015-04-21 |
| Regorafenib Phase I Study in Mainland Chinese Patients (NCT02398513) | Bayer | 2015-04-01 |
| Percutaneous Transluminal Forceps Biopsy (NCT06039670) | University Hospital, Caen | 2015-01-02 |
| A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma (NCT02110355) | Kartos Therapeutics, Inc. | 2014-12-19 |
| Sarah Cannon Outcomes Registry (NCT02356822) | SCRI Development Innovations, LLC | 2014-12-01 |
| Development and Evaluation of THRIVE (NCT03806140) | Children's Hospital of Philadelphia | 2014-07-01 |
| A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia (NCT02016729) | Kartos Therapeutics, Inc. | 2014-04-01 |
| A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (NCT01853306) | AbbVie | 2013-03-18 |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma (NCT01723020) | Kartos Therapeutics, Inc. | 2012-12-27 |
| Study of a Predictor for Cervix Cancer (NCT01641484) | Centre Oscar Lambret | 2012-01-01 |
| Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. (NCT01439152) | Bayer | 2011-09-07 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| AMG 319 Lymphoid Malignancy FIH (NCT01300026) | Amgen | 2011-04-01 |
| The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With Cancer (NCT01108952) | Tel-Aviv Sourasky Medical Center | 2011-01-01 |
| Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute (NCT05607186) | Singapore General Hospital | 2011-01-01 |
| A Study of AMG 337 in Subjects With Advanced Solid Tumors (NCT01253707) | Amgen | 2010-12-08 |
| Pretreatment Quality of Life as a Predictor of Distant Metastasis-Free Survival and Overall Survival in Patients With Head and Neck Cancer (NCT03290352) | Taipei Medical University | 2010-11-01 |
| Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer (NCT03061370) | St. James's Hospital, Ireland | 2010-01-01 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859) | Amgen | 2009-03-09 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (NCT00770536) | Amgen | 2009-01-01 |
| A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors (NCT00813384) | Amgen | 2008-12-01 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors (NCT01444404) | AmMax Bio, Inc. | 2008-03-31 |
| Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study (NCT00630786) | Amgen | 2008-01-01 |
| Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00547157) | Amgen | 2007-11-01 |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) (NCT00446446) | Amgen | 2007-10-30 |
| Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study (NCT07180173) | Taichung Veterans General Hospital | 2007-04-01 |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) (NCT00413283) | Amgen | 2006-12-01 |
| Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment (NCT00411450) | Amgen | 2006-11-01 |
| Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer (NCT00352950) | Amgen | 2006-03-01 |
| A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma (NCT00283439) | Amgen | 2005-10-01 |
| Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors (NCT00091806) | Amgen | 2004-08-01 |
| Pegfilgrastim PBPC Mobilization Study (NCT00066092) | Amgen | 2003-04-01 |
| Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA (NCT00588289) | Memorial Sloan Kettering Cancer Center | 1999-09-01 |
| MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer (NCT06980519) | Monopar Therapeutics | |